Press release
Liposome Drug Delivery Market Size 2023-2030: Johnson and Johnson, Gilead Sciences, Novartis, Sun Pharmaceutical
Liposome Drug Delivery Market
Liposome drug delivery is a way of administering a medication that increases its bioavailability and reduces toxicity. Liposomes are tiny vesicles made from naturally occurring molecules in the body, which can transport drugs into targeted cells for improved effectiveness while reducing side effects compared to conventional methods like intravenous injections or oral medications. The Liposome-mediated drug delivery technology is one of the most promising approaches to treating cancers and other diseases.
Click Here For a Free Sample + Related Graphs of the Report at: https://www.delvens.com/get-free-sample/liposome-drug-delivery-market-trends-forecast-till-2030
Liposome Drug Delivery Market by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, DepoFoam Liposome Technology, Lysolipid Thermally Sensitive Liposome (LTSL)); Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Top Players covered in Liposome Drug Delivery Market report: Johnson and Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma, Sigma-Tau Group, Fudan-Zhangjiang, Teva Pharmaceutical, CSPC, Novartis, Kingond Pharm, Spectrum Pharmaceuticals, Shanghai New Asia
June 17th, 2020: Ipsen Pharma announced that it has received the Fast Track designation by the United States Food and Drug Administration (FDA) for the investigational use of liposomal irinotecan (ONIVYDE) in combination with oxaliplatin (OX) and 5-fluorouracil/leucovorin (5-FU/LV) together.
December 9th, 2019: FUJIFILM Toyama Chemical Co., Ltd. announced that it has completed its first manufacturing facility named 701 for liposome formulation in Japan.
The growth of the market can be attributed to the rising prevalence of cancer, and therefore the need for advanced drug delivery systems for the treatment of the disease. the rising focus of healthcare researchers on developing targeted drug delivery systems (TDDS) is also expected to create numerous opportunities for market growth. Furthermore, the factors that will enhance the growth of the market are the Growing geriatric population base across the world, high unmet medical needs owing to the increasing number of drug-resistant diseases, and increased use of liposomes for therapeutic purposes due to their advantages over other delivery systems such as injection, oral pill formulations.
On the other hand, High production cost is the major reason behind the hindrance of market growth. Additionally, low solubility and short half-life of liposomes can negatively affect the preference rate, hindering the growth of the Liposomes Drug Delivery Market.
An increase has been witnessed in the demand for medical supplies to take care of the infected population. Respiratory support devices such as atomizers, life support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. The need for medical supplies has increased significantly among both healthcare professionals and the civil population for precautionary measures, owing to the rise in the number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure an adequate and continuous supply of personal protective equipment in the market. Therefore, COVID-19 is expected to have a significant impact on the global liposome drug delivery market.
To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/liposome-drug-delivery-market-trends-forecast-till-2030
Liposome Drug Delivery Market is segmented into various segments such as product, technology, application and region:
On the basis of product
Liposomal Doxorubicin
Liposomal Paclitaxel
Liposomal Amphotericin B
Others
On the basis of technology
Stealth Liposome Technology
Non-PEGylated Liposome Technology
DepoFoam Liposome Technology
Lysolipid Thermally Sensitive Liposome (LTSL) Technology
On the basis of application
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy
On the basis of region
Asia Pacific
North America
Europe
South America
Middle East & Africa
North America to Dominate the Market
The market in North America is projected to be the largest revenue share and is anticipated to maintain its dominance over the forecast period.
The growth of the market in the region can primarily be attributed to the increasing prevalence of cancer in the region, followed by the surge in government initiatives that promote research and development for cancer drugs and drug delivery systems, along with the surge in healthcare expenditure in the region.
In the upcoming years, the desire for targeted drug delivery, the prevalence of chronic illnesses, and developments in liposome technology are projected to generate a large increase in the market for liposome drug delivery. Although there are many businesses operating in the industry, which is extremely fragmented, it is also fiercely competitive, with a few significant firms controlling the majority of the market share. The market is anticipated to be dominated by North America and Europe, but the Asia-Pacific region is anticipated to have considerable growth because of increased healthcare spending and the prevalence of chronic illnesses there. Johnson & Johnson, Pfizer, Inc., Gilead Sciences, Inc., Teva Pharmaceutical Industries Ltd., and Sun Pharmaceutical Industries Ltd. are a few of the market's top competitors. In the upcoming years, consolidation is predicted to continue as bigger competitors buy smaller rivals to broaden their product lines and boost their market share.
Purchase This Report: https://www.delvens.com/checkout/liposome-drug-delivery-market-trends-forecast-till-2030
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
SALES@DELVENS.COM
WEBSITE: https://delvens.com/
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liposome Drug Delivery Market Size 2023-2030: Johnson and Johnson, Gilead Sciences, Novartis, Sun Pharmaceutical here
News-ID: 3090457 • Views: …
More Releases from Delvens
Flow Wrap Packaging Market with Growth, Trends and Top Key Competitors Analysis
Flow Wrap Packaging Market size was estimated at USD 22,364 million in 2024 and is projected to reach USD 37,833.8 million in 2031 at a CAGR of 7.8 % during the forecast period 2025-2031.
Flow wrap packaging is popular due to its ability to provide efficient, high-speed packaging while maintaining the integrity of the product inside. The material typically used for flow wrap packaging includes plastic films like polypropylene, polyethylene, and…
Oil and Gas Process Simulation Software Market Global Analysis by Component, Ope …
Oil and Gas Process Simulation Software Market: by Component (Software and Services), Operation Type (Off-Shore, On-Shore, Heavy Oil and Unconventional), Application (Upstream, Midstream, Oil and Gas Processing, Cryogenic Processes, Refining, Petrochemicals and Green Engineering), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The Oil and Gas Process Simulation Software Market size was estimated at USD 1.14 billion in 2023 and is projected to reach USD…
Digital Banking Market Business Growth: Alkami, Apiture, Appway, Backbase, BNY M …
Digital Banking Market Size By Service (Transactional [Cash Deposits & Withdrawals, Fund Transfers, Auto-Debit/Auto-Credit Services, Loans], Non-Transactional [Information Security, Risk Management, Financial Planning, Stock Advisory]) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The global Digital Banking Market size was estimated at USD 8341.2 Billion in 2023 and is projected to reach USD 11374.2 billion in 2030 at a CAGR of 4.1% during the forecast…
Business Process Outsourcing (BPO) Market Demands, Shares, Overview, Growth, Bus …
The market for business process outsourcing (BPO) is expanding as a result of factors such as businesses' increasing emphasis on enhancing productivity and organizational agility, cutting costs, and accelerating key capabilities to survive the rapidly changing business dynamics. Additionally, a lot of businesses are concentrating on lowering their operating expenses so they can access global resources to satisfy the rising market needs. These factors have promoted the use of market…
More Releases for Liposome
Irinotecan Hydrochloride Liposome Injection Market Forecast to 2034
Market Overview
As of 2024, the Irinotecan Hydrochloride Liposome Injection Market is valued at USD 116 million. It is expected to grow at a Compound Annual Growth Rate (CAGR) of 10.1% from 2024 to 2034, reaching approximately USD 305 million by 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/59123
Key Market Highlights:
• Base Year: 2023
• Forecast Period: 2024-2034
• 2024 Market Size: USD 116 Million
• 2034 Forecasted Size: USD 305 Million
• CAGR: 10.1%
• Primary Driver: Rising prevalence of…
Doxorubicin Hydrochloride Liposome Injection Market Size, Share and Growth Repor …
" The global market for Doxorubicin Hydrochloride Liposome Injection is projected to reach approximately $1.2 billion in 2024. The forecast period from 2025 to 2034 is expected to witness significant expansion, with a projected market value increasing to around $2.5 billion by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of approximately 8.1% during the forecast period, driven by rising incidences of various cancers, advancements in liposomal drug…
Liposome Drug Delivery Market Future Prediction Report By 2031
A new market study report by The Insight Partners on the Liposome Drug Delivery Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period.
Get PDF Sample Report…
Liposome Makeover: How Creative Biolabs is Amping Up Drug Delivery
Creative Biolabs is at the forefront of the liposome "revolution", offering cutting-edge liposome development services tailored to meet the complex needs of researchers and pharmaceutical companies.
New York, USA - September 11, 2024 - As the biotech and pharmaceutical sectors continue their rapid evolution, the demand for innovative and efficient drug delivery systems has reached an all-time high. One of the most promising developments in this field has been the use…
Turkey Liposome Drug Delivery Market Trends and Growth Factors Analysis
The global liposome drug delivery market is estimated to attain a valuation of ~US$ 8 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of ~9% during the forecast period, 2019 to 2027.
The key objective of the TMR report is to offer a complete assessment of the global market including major…
Liposome in Cosmetics Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Liposome in Cosmetics market.
Liposomes are spherical vesicles in which their central aqueous section is surrounded by one or more of a bilayer membrane (Lamella) that is frequently enclosed by aquatic environments. These vesicles are formed when amphiphilic lipids confront with aqueous milieu. They can vary in size from 15 nm to several microns. In the…
